Search research articles
Contact Us
Filters
Showing results (1-10 of 140) with videos related to
Page
of 14
Sort By:
Frontiers in Pharmacology
|
May 25, 2011
Pharmacogenetics - challenges and opportunities ahead
Ulrich M Zanger
Pharmacology & Therapeutics
|
January 22, 2013
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M Zanger, Matthias Schwab
Frontiers in Genetics
|
March 8, 2013
Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
Ulrich M Zanger, Kathrin Klein
Frontiers in Genetics
|
February 28, 2013
Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the "Missing Heritability" Problem
Kathrin Klein, Ulrich M Zanger
Drug Metabolism and Drug Interactions
|
November 16, 2012
Cytochrome P450 2B6: function, genetics, and clinical relevance
Miia Turpeinen, Ulrich M Zanger
Biochemical Pharmacology
|
November 24, 2019
MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation
Nicole Kugler, Kathrin Klein, Ulrich M Zanger
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
November 18, 2003
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
Ulrich M Zanger, Sebastian Raimundo, Michel Eichelbaum
Frontiers in Pharmacology
|
April 12, 2017
Membrane Associated Progesterone Receptors: Promiscuous Proteins with Pleiotropic Functions - Focus on Interactions with Cytochromes P450
Chang S Ryu, Kathrin Klein, Ulrich M Zanger
Annual Review of Pharmacology and Toxicology
|
November 13, 2012
Omics and drug response
Urs A Meyer, Ulrich M Zanger, Matthias Schwab
Genetic Testing
|
July 30, 2003
Mutational analysis of the human dihydropyrimidine dehydrogenase gene by denaturing high-performance liquid chromatography
Joachim Fischer, Matthias Schwab, Michel Eichelbaum, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 140) with videos related to
Sort By:
Page
of 14
Frontiers in Pharmacology
|
May 25, 2011
Pharmacogenetics - challenges and opportunities ahead
Ulrich M Zanger
Pharmacology & Therapeutics
|
January 22, 2013
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M Zanger, Matthias Schwab
Frontiers in Genetics
|
March 8, 2013
Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
Ulrich M Zanger, Kathrin Klein
Frontiers in Genetics
|
February 28, 2013
Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the "Missing Heritability" Problem
Kathrin Klein, Ulrich M Zanger
Drug Metabolism and Drug Interactions
|
November 16, 2012
Cytochrome P450 2B6: function, genetics, and clinical relevance
Miia Turpeinen, Ulrich M Zanger
Biochemical Pharmacology
|
November 24, 2019
MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation
Nicole Kugler, Kathrin Klein, Ulrich M Zanger
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
November 18, 2003
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
Ulrich M Zanger, Sebastian Raimundo, Michel Eichelbaum
Frontiers in Pharmacology
|
April 12, 2017
Membrane Associated Progesterone Receptors: Promiscuous Proteins with Pleiotropic Functions - Focus on Interactions with Cytochromes P450
Chang S Ryu, Kathrin Klein, Ulrich M Zanger
Annual Review of Pharmacology and Toxicology
|
November 13, 2012
Omics and drug response
Urs A Meyer, Ulrich M Zanger, Matthias Schwab
Genetic Testing
|
July 30, 2003
Mutational analysis of the human dihydropyrimidine dehydrogenase gene by denaturing high-performance liquid chromatography
Joachim Fischer, Matthias Schwab, Michel Eichelbaum, et al.
Page
of 14